Product Code: ETC095057 | Publication Date: Jul 2023 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
Ampicillin, a member of the penicillin family, is an antibiotic used for treating bacterial infections such as respiratory tract infections and urinary tract infections. It is also effective against some gastrointestinal, skin, and soft tissue infections. The market for ampicillin in Kazakhstan has been growing steadily due to the rise in the prevalence of infectious diseases and increasing awareness about antibiotics among physicians and consumers.
The primary drivers for the increasing demand for ampicillin in Kazakhstan include the rising prevalence of infectious diseases, increasing awareness about antibiotics among healthcare providers and the general public, availability of generic drugs at low prices, rapid urbanization leading to crowded living conditions which act as breeding grounds for germs/pathogens that can lead to infection outbreaks etc. Additionally, government initiatives towards improving healthcare infrastructure have resulted in increased access to quality medical care which has further boosted the usage rate of ampicillin products across various regions within Kazakhstan.
The major challenge faced by this market is related to resistance development due to widespread use of antibacterial agents. This issue occurs when bacteria become resistant or less vulnerable to certain antibiotics like ampicillin over time causing treatment failure even with higher doses than normal amount prescribed by physicians/doctors or when used inappropriately (wrong dosage or wrong duration). Other challenges include lack of skilled labor & resources in developing countries where most people opt out traditional treatments rather seeking professional help from doctors due health illiteracy issues prevalent among population living under poverty line etc., stringent regulations on pricing coupled with high cost associated with research & development activities necessary before launching any new drug into market further adding up pressure on manufacturers??? bottom-line profits, etc.
Some key players operating within Kazakhstani market are Bayer AG (Germany), Pfizer Inc.(USA), Novartis International AG(Switzerland) , Sanofi Aventis SA(France) , AstraZeneca Pharmaceuticals LP(UK) , GlaxoSmithKline plc (UK), Sun Pharmaceutical Industries Ltd.(India), Teva Pharmaceutical Industries Ltd.(Israel)etc.. These companies offer variety product portfolio ranging from capsules containing different concentration levels such as 250mg five times daily till suspension bottles available both refrigerated & non-refrigerated forms thereby catering wide range customer base according their needs budget constraints faced while purchasing these drugs directly form retail stores/ pharmacies.
The Covid-19 pandemic has had a significant impact on the pharmaceutical industry in Kazakhstan. The demand for ampicillin, an antibiotic used to treat infections caused by bacteria, has decreased due to the lockdown and reduced economic activity as a result of Covid-19. This is because people are not able to seek medical care or purchase antibiotics such as ampicillin due to restrictions on movement and businesses. In addition, pharmacies have had difficulty sourcing drugs from overseas suppliers due to disruptions in global supply chains which have resulted from international travel restrictions and border closures. This has led to shortages of certain medications including ampicillin across Kazakhstan.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kazakhstan Ampicillin Market Overview |
3.1 Kazakhstan Country Macro Economic Indicators |
3.2 Kazakhstan Ampicillin Market Revenues & Volume, 2020 & 2027F |
3.3 Kazakhstan Ampicillin Market - Industry Life Cycle |
3.4 Kazakhstan Ampicillin Market - Porter's Five Forces |
3.5 Kazakhstan Ampicillin Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 Kazakhstan Ampicillin Market Revenues & Volume Share, By Application, 2020 & 2027F |
4 Kazakhstan Ampicillin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Kazakhstan Ampicillin Market Trends |
6 Kazakhstan Ampicillin Market, By Types |
6.1 Kazakhstan Ampicillin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Kazakhstan Ampicillin Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Kazakhstan Ampicillin Market Revenues & Volume, By Ampicillin Capsules, 2018 - 2027F |
6.1.4 Kazakhstan Ampicillin Market Revenues & Volume, By Ampicillin Sodium, 2018 - 2027F |
6.1.5 Kazakhstan Ampicillin Market Revenues & Volume, By Ampicillin Granules, 2018 - 2027F |
6.1.6 Kazakhstan Ampicillin Market Revenues & Volume, By Ampicillin Tablets, 2018 - 2027F |
6.1.7 Kazakhstan Ampicillin Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 Kazakhstan Ampicillin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Kazakhstan Ampicillin Market Revenues & Volume, By Adults, 2018 - 2027F |
6.2.3 Kazakhstan Ampicillin Market Revenues & Volume, By Kids, 2018 - 2027F |
6.2.4 Kazakhstan Ampicillin Market Revenues & Volume, By Others, 2018 - 2027F |
7 Kazakhstan Ampicillin Market Import-Export Trade Statistics |
7.1 Kazakhstan Ampicillin Market Export to Major Countries |
7.2 Kazakhstan Ampicillin Market Imports from Major Countries |
8 Kazakhstan Ampicillin Market Key Performance Indicators |
9 Kazakhstan Ampicillin Market - Opportunity Assessment |
9.1 Kazakhstan Ampicillin Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 Kazakhstan Ampicillin Market Opportunity Assessment, By Application, 2020 & 2027F |
10 Kazakhstan Ampicillin Market - Competitive Landscape |
10.1 Kazakhstan Ampicillin Market Revenue Share, By Companies, 2020 |
10.2 Kazakhstan Ampicillin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |